Search - tctmd.com

Displaying 781 - 800 of 2963

Sort: Relevancy | Date

Presentation TCT 2017

Mortality and Stroke After PCI vs CABG In Left Main and 3VD: An Individual Patient Data Meta-analysis

Presenter: Dean J. Kereiakes, Spencer B. King III, A. Pieter Kappetein

October 30, 2017

Presentation TCT 2017

Influence of Diversity: Should Sex, Race, and Ethnicity Affect Revascularization Decisions? Does It?

Presenter: Dean J. Kereiakes, Spencer B. King III, Roxana Mehran

October 30, 2017

Presentation TCT 2017

My Stepwise Approach to Bifurcations to Decide Between 1 and 2 Stents (With Case Examples)

Presenter: Terje K. Steigen, Leif Thuesen, Yves R. Louvard

October 30, 2017

Presentation TCT 2017

Impact of Mandatory Stent Price Controls 2: My New Insights From Inside Industry

Presenter: Dean J. Kereiakes, Spencer B. King III, Ian T. Meredith

October 30, 2017

Presentation TCT 2017

Bifurcation Stents 1: TRYTON Description, Data, and Case Examples

Presenter: Alaide Chieffo, Jeffrey W. Moses, Philippe Genereux

October 30, 2017

Presentation TCT 2017

Impact of Mandatory Stent Price Controls 1: Physician Perspectives

Presenter: Dean J. Kereiakes, Spencer B. King III, Upendra Kaul

October 30, 2017

Presentation TCT 2017

Treatment of Coronary Bifurcations in the Contemporary Era of P2Y12 Inhibitors and "Biologically Active Stents"

Presenter: Davide Capodanno, David Hildick-Smith, Marco Zimarino

October 30, 2017

Presentation TCT 2017

Impact of AUC and Public Reporting: Is PCI Now More Appropriate?

Presenter: Dean J. Kereiakes, Spencer B. King III, Michael A. Kutcher

October 30, 2017

Presentation TCT 2017

Bifurcation Stents 4: NILE Description, Data, and Case Examples

Presenter: Alaide Chieffo, Jeffrey W. Moses, Ivo Petrov

October 30, 2017

Presentation TCT 2017

Bifurcation Stents 3: BIOSS Description, Data, and Case Examples

Presenter: Alaide Chieffo, Jeffrey W. Moses, Ricardo A. Costa

October 30, 2017

Presentation TCT 2017

Metallic DES: What Can We Expect From New Drugs, Polymers, and Metals? Have We Reached the Limit of Iterative Development?

Presenter: Dean J. Kereiakes, Spencer B. King III, Elazer R. Edelman

October 30, 2017

Presentation TCT 2017

Bifurcation Stents 2: AXXESS Plus Description, Data, and Case Examples

Presenter: Alaide Chieffo, Jeffrey W. Moses, Fausto Feres

October 30, 2017

Presentation TCT 2017

Is There a Role for Dedicated Stents or Bioresorbable Scaffolds in the Treatment of Complex Bifurcation Disease?

Presenter: Walter Desmet, Guy J. Friedrich, Eduard Margetic, Christophe Dubois

October 30, 2017

Presentation TCT 2017

New Insights Into Neoatherosclerosis and Other Causes of Metallic Stent Thrombosis: Will the Most Dreaded Complication Always Be With Us?

Presenter: Dean J. Kereiakes, Spencer B. King III, Aloke V. Finn

October 30, 2017

Presentation TCT 2017

Is There a Need for Dedicated Bifurcation Stents (Bare Metal or Drug-Eluting)?

Presenter: Alaide Chieffo, Jeffrey W. Moses, Martin B. Leon

October 30, 2017

Presentation TCT 2017

Very Late Stent Failures and Non-Stent Related Events: Insights Into Improving Event-Free Survival

Presenter: Dean J. Kereiakes, Spencer B. King III, Lorenz Raber

October 30, 2017

Presentation TCT 2017

Keynote Lecture: A Brief 40-Year History of PCI - How Far We've Come, How Far We Have to Go

Presenter: Dean J. Kereiakes, Spencer B. King III, Robert A. Byrne

October 30, 2017

Presentation TCT 2017

Small Vessel Stenting Snapshot 2: The Svelte Sirolimus-Eluting Stent

Presenter: Julinda Mehilli, Giulio G. Stefanini, Sunil V. Rao

October 30, 2017

Presentation TCT 2017

Small Vessel Stenting Snapshot 1: The Onyx 2.0 Zotarolimus-Eluting Stent

Presenter: Julinda Mehilli, Giulio G. Stefanini, Matthew J. Price

October 30, 2017

Presentation TCT 2017

Outcomes With the Stentys Self-Expanding DES in STEMI and Other Clinical Scenarios

Presenter: Julinda Mehilli, Giulio G. Stefanini, Roxana Mehran

October 30, 2017

Advertisement

Mortality and Stroke After PCI vs CABG In Left Main and 3VD: An Individual Patient Data Meta-analysis

Influence of Diversity: Should Sex, Race, and Ethnicity Affect Revascularization Decisions? Does It?

My Stepwise Approach to Bifurcations to Decide Between 1 and 2 Stents (With Case Examples)

Impact of Mandatory Stent Price Controls 2: My New Insights From Inside Industry

Bifurcation Stents 1: TRYTON Description, Data, and Case Examples

Impact of Mandatory Stent Price Controls 1: Physician Perspectives

Treatment of Coronary Bifurcations in the Contemporary Era of P2Y12 Inhibitors and "Biologically Active Stents"

Impact of AUC and Public Reporting: Is PCI Now More Appropriate?

Bifurcation Stents 4: NILE Description, Data, and Case Examples

Bifurcation Stents 3: BIOSS Description, Data, and Case Examples

Metallic DES: What Can We Expect From New Drugs, Polymers, and Metals? Have We Reached the Limit of Iterative Development?

Bifurcation Stents 2: AXXESS Plus Description, Data, and Case Examples

Is There a Role for Dedicated Stents or Bioresorbable Scaffolds in the Treatment of Complex Bifurcation Disease?

New Insights Into Neoatherosclerosis and Other Causes of Metallic Stent Thrombosis: Will the Most Dreaded Complication Always Be With Us?

Is There a Need for Dedicated Bifurcation Stents (Bare Metal or Drug-Eluting)?

Very Late Stent Failures and Non-Stent Related Events: Insights Into Improving Event-Free Survival

Keynote Lecture: A Brief 40-Year History of PCI - How Far We've Come, How Far We Have to Go

Small Vessel Stenting Snapshot 2: The Svelte Sirolimus-Eluting Stent

Small Vessel Stenting Snapshot 1: The Onyx 2.0 Zotarolimus-Eluting Stent

Outcomes With the Stentys Self-Expanding DES in STEMI and Other Clinical Scenarios

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content